Canadian Reimbursement and Forecasting Timelines (CRaFT) Report

MORSE Consulting will be launching our 2024 Canadian Reimbursement and Forecasting Timelines (CRaFT) Subscription in May.

Download a Sample of the Report.

A CRaFT Subscription provides clients with access to in-depth public market access volume and timeline analyses using MORSE’s robust public payer dataset, paired with insights tapped from MORSE’s unparalleled HTA and public payer expertise.  

This year’s CRaFT Subscription includes access to the following:  

• 2024 edition of CRaFT Report, encompassing: 
  • CADTH volume & timeline metrics 
  • CADTH & INESSS alignment in recommendations 
  • pCPA volume & timeline metrics, and negotiation trends 
  • Provincial funding volume & timeline metrics 
  • Data stratification by Oncology, Non-Oncology, Biosimilars, and Others 
  • NEW Targeted Negotiation Process (TNP) analysis  
• NEW Monthly Market Access Update, which will provide timely and up-to-date information on files moving through the market access process, including an in-depth analysis of CADTH and pCPA metrics with relevant insights on emerging trends.
• NEW Mid-year Update of listing data from BC, AB, ON, and QC

Additionally, this year’s add-ons for purchase include:  

• Drug for Rare Diseases (DRD) sub-report  
• NEW “customizable” indication-specific sub-report 

Together, these reports and insights are a comprehensive source of reimbursement timeline information to assist companies with their upcoming Canadian launch.